Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Med Genet A ; 185(12): 3872-3876, 2021 12.
Article in English | MEDLINE | ID: mdl-34313384

ABSTRACT

Pheochromocytoma/paraganglioma (Pheo/PGL) associated with pituitary adenoma (PA) is rare in clinical practice, and a common pathogenic mechanism has been suggested owing to the germline pathogenic variants found in some cases. Our aim is to propose a reassignment for a recurrent MEN1 genetic variant found in a 54-year-old male patient with bilateral pheochromocytoma and GH-secreting PA. Pheo/PGL genes study was carried out in DNA samples from Pheo as well as PA and no pathological variants or large deletions were detected. Additionally, a MEN1 gene analysis was performed, and a heterozygous germline variant in exon 10: c.1618C>T; p.(Pro540Ser) was found. No MEN1 gene deletions/duplications were detected. In evaluating a causal relationship between the c.1618C>T MEN1 variant and both tumors, we took into account that missense variants are common pathogenic variants in MEN1, and the population frequency of this variant is too high to be considered pathogenic. His son (aged 38 and carrier) is asymptomatic, and computational analysis showed discrepancies. We propose that this recurrent variant, previously considered as likely pathogenic, subsequently as variant of uncertain significance, and likely benign should now be reclassified as benign.


Subject(s)
Paraganglioma/genetics , Pheochromocytoma/genetics , Pituitary Neoplasms/genetics , Proto-Oncogene Proteins/genetics , Adult , Germ-Line Mutation , Heterozygote , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Paraganglioma/complications , Paraganglioma/pathology , Pheochromocytoma/complications , Pheochromocytoma/pathology , Pituitary Neoplasms/complications , Pituitary Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...